electroCore to Participate in the JMP Securities MedTech Bio Summit

BASKING RIDGE, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc.(Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief executive officer, will participate in a fireside chat at the JMP Securities MedTech Bio Summit, which is being held virtually October 1-2, 2020.

Metadata
Provider: 
GlobeNewswire, Inc.GlobeNewswire, Inc.
Retrieved on: 
Wednesday, September 23, 2020
Information
Tags: 
Medicine, Clinical medicine, Health care, ElectroCore, Headaches, Pain management, Cluster headache, Migraine, Vagus nerve stimulation, Headache
Geotags: 
Us
Organisation: 
ELECTROCORE
Summary
Key Points: 
  • BASKING RIDGE, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc.(Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief executive officer, will participate in a fireside chat at the JMP Securities MedTech Bio Summit, which is being held virtually October 1-2, 2020.
  • Audio from the event will be webcast live and available here or on the Investors section of the companys website.
  • electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology.
  • The companys current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.


BASKING RIDGE, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief executive officer, will participate in a fireside chat at the JMP Securities MedTech Bio Summit, which is being held virtually October 1-2, 2020.

Event details:

Date: Thursday, October 1, 2020
Time: 2:00pm ET

Audio from the event will be webcast live and available here or on the Investors section of the company’s website.

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

Investors:
Hans Vitzthum
LifeSci Advisors
617-430-7578
[email protected]

or

Media Contact:
Jackie Dorsky
electroCore
973-290-0097

Primary Logo
Copyright: 
2020 GlobeNewswire, Inc.. All Rights Reserved.